Press Releases Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Delayed NSE India S.E. Other stock markets 04:20:21 2024-05-03 am EDT			5-day change	1st Jan Change
1,056 ^INR	-0.47%		+1.98%	+23.54%

Apr. 29	Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines	MT
Apr. 25	Glenmark Lifesciences' Net Profit Slides in Fiscal Q4	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	Feb. 15	AQ
Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance 'Ichnos Glenmark Innovation'	Jan. 31	AQ
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 for Multiple Geographies around the World	Jan. 26	AQ
Glenmark Pharmaceuticals : is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India	Jan. 03	PU
Glenmark Pharma is first to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes in Adults with Co-morbidities	23-10-19	AQ
Fitch Affirms Glenmark Pharmaceuticals at 'BB'; Outlook Stable	23-10-04	AQ
COSMO AND GLENMARK ANNOUNCE THE SIGNING OF DISTRIBUTION AND LICENSE AGREEMENTS FOR WINLEVI IN EUROPE AND SOUTH AFRICA	23-09-28	AQ
Glenmark Pharmaceuticals : FY 2022-23	23-09-04	PU
Glenmark Pharmaceuticals : Q1FY 2023-24	23-08-21	PU
Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%	23-08-18	AQ
Glenmark Pharma reports revenue growth of 22.5%, EBITDA growth of 46.2% YoY for Q1 FY 2023 24	23-08-14	AQ
Glenmark Pharmaceuticals receives ANDA approval for Saxagliptin Tablets, 2.5 mg and 5 mg	23-08-01	AQ
Fitch Affirms Glenmark Pharmaceuticals at 'BB'; Outlook Stable	23-06-20	AQ
Glenmark Pharmaceuticals : Q4FY 2022-23	23-05-24	PU
Glenmark Pharmaceuticals is Great Place to Work Certified in India	23-03-27	AQ
Glenmark Pharmaceuticals : receives ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%\|0.064%	23-03-23	PU
Glenmark Pharmaceuticals receives ANDA approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg	23-03-20	AQ
Glenmark Pharmaceuticals : receives acceptance from U.S. FDA on its IND application for GRC 54276 to proceed with a Phase 1/2, first-in-human clinical study of the molecule for the treatment of patients with advanced solid tumors and lymphomas	23-03-16	PU
Glenmark Pharmaceuticals : receives ANDA approval for Clindamycin Hydrochloride Capsules USP, 75 mg, 150 mg, and 300 mg	23-03-14	PU
Glenmark and Cediprof Announce Exclusive Distribution Agreement in the United States	23-03-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Press Releases

Filters